SEC Form 4 · accession 0001209191-16-111042
Zosano Pharma Corp · ZSAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Winnie Wing-Kei Tso
Officer — Chief Financial Officer
Period of report
Mar 29, 2016
Accepted (ET)
Mar 30, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001587221
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $2.57 | Mar 29, 2016 | A | 15,000 | A | — | Mar 29, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F125% of the total number of shares underlying the stock option vest on March 29, 2017, and the remaining underlying shares vest in equal monthly installments over the following three-year period.